About 60% of CRC cases have CDK8 (cyclin-dependent kinase-8) gene amplification, another genetic alteration that modify β-catenin activity; higher CDK8 levels stimulate neurogenic locus notch homolog protein 1 (Notch1) and β-catenin to promote cell differentiation (40). The gene discussed is CDK8; the disease is colorectal carcinoma.